Literature DB >> 94699

Colorectal carcinoma antigens detected by hybridoma antibodies.

H Koprowski, Z Steplewski, K Mitchell, M Herlyn, D Herlyn, P Fuhrer.   

Abstract

Hybridoma cells which secrete colorectal carcinoma-specific antibodies have been produced and used to study the antigenic structure of these tumor cells. Nineteen antibodies have been studied in detail, and 15 of these are colorectal carcinoma specific. Only two antibodies reactive with carcinoembryonic antigen (CEA) have been discovered and five other antibodies that react with distinct epitopes on the cell surface have been defined. Several antigens with distinct molecular characteristics have been shown to exist by use of hybridoma antibodies. Six hybridoma antibodies have been shown to mediate antibody-dependent cell-mediated cytotoxicity (ADCC).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94699     DOI: 10.1007/bf01542654

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  292 in total

1.  The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer.

Authors:  C X Zheng; W H Zhan; J Z Zhao; D Zheng; D P Wang; Y L He; Z Q Zheng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer.

Authors:  Yoshichika Oishi; Yoshiyuki Watanabe; Yoshihito Yoshida; Yoshinori Sato; Tetsuya Hiraishi; Ritsuko Oikawa; Tadateru Maehata; Hiromu Suzuki; Minoru Toyota; Hirohumi Niwa; Michihiro Suzuki; Fumio Itoh
Journal:  Tumour Biol       Date:  2011-12-08

3.  The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.

Authors:  Sundeep Singh; Shou-jiang Tang; Jayaprakash Sreenarasimhaiah; Luis F Lara; Ali Siddiqui
Journal:  Dig Dis Sci       Date:  2011-04-23       Impact factor: 3.199

4.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Authors:  Xing-Lei Qin; Zhuo-Ren Wang; Jing-Sen Shi; Min Lu; Lin Wang; Quan-Ru He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

5.  Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model.

Authors:  Y Nemoto-Sasaki; M Mitsuki; M Morimoto-Tomita; A Maeda; M Tsuiji; T Irimura
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

6.  Determination of tumor marker levels in cystic fluid of benign liver cysts.

Authors:  K Iwase; H Takenaka; S Oshima; A Yagura; Y Nishimura; K Yoshidome; T Tanaka
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

7.  Pharmacokinetic study of radiolabeled anti-colorectal carcinoma monoclonal antibodies in tumor-bearing nude mice.

Authors:  J Y Douillard; J F Chatal; J C Saccavini; C Curtet; M Kremer; P Peuvrel; H Koprowski
Journal:  Eur J Nucl Med       Date:  1985

8.  Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

Authors:  F Buchegger; C Pfister; K Fournier; F Prevel; M Schreyer; S Carrel; J P Mach
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

9.  Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.

Authors:  H Koho; S Paulie; H Ben-Aissa; I Jónsdóttir; Y Hansson; M L Lundblad; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.

Authors:  J Holmgren; L Lindholm; B Persson; T Lagergård; O Nilsson; L Svennerholm; C M Rudenstam; B Unsgaard; F Yngvason; S Pettersson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.